Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 6 minute read Pharma Industry News Technology Industry News Biotech meets blockchain: AlphaTON to tokenize cancer drug rights ahead of 2026 trial Find out how AlphaTON and Cyncado plan to merge blockchain and biotech through tokenized cancer drug rights before their 2026 clinical trial begins. bySoujanya RaviOctober 8, 2025